Suchergebnisse - "Shi, Yuankai"

PubPharm (23)

21

Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases

enthalten in: Current cancer drug targets | 2019

von Song, Y. | Liu, P. | Huang, Y. | +3

22

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

enthalten in: Cancer biology & medicine | 2018

von Wang, J. | Zhao, Y. | Wang, Q. | +18

23

Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Si, X. | Zhang, L. | Wang, H. | +19